Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Deciphering the role of tumor cell-intrinsic Sema4D in TNBC mouse tumor using single-cell RNA sequencing

ABSTRACT: Deciphering the role of tumor cell-intrinsic Sema4D in TNBC mouse tumor using single-cell RNA sequencing

PROVIDER: PRJNA1311343 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Deciphering the role of tumor cell-intrinsic Sema4D in TNBC mouse tumor using single-cell RNA sequencing

Project description:Sema4D (Semaphorin 4D, also known as CD100) is a member of the class IV semaphorin family and is predominantly expressed on the surface of lymphocytes, monocytes, macrophages, and endothelial cells. The current understanding of Sema4D function is focused on its receptor-mediated signaling activities with limited data on its intrinsic mechanisms. However, the immunological roles and functional mechanism of tumor cell-intrinsic Sema4D regulating immune escape remain largely unknown. This study employs single-cell RNA sequencing (scRNA-seq) to investigate cellular and regulatory role of Sema4d in TNBC mouse tumors.

2025-08-31 | GSE306581 | GEO

Inhibiting tumor cell-intrinsic UBA6 by inosine augments tumor immunogenicity

Project description:Inhibiting tumor cell-intrinsic UBA6 by inosine augments tumor immunogenicity

| PRJNA864795 | ENA

Chromosome 9p21.3 Coordinates Cell Intrinsic and Extrinsic Tumor Suppression

Project description:Chromosome 9p21.3 Coordinates Cell Intrinsic and Extrinsic Tumor Suppression

| PRJNA866374 | ENA

Tumor cell-intrinsic Decr2 is necessary for immunotherapy efficacy

Project description:Tumor cell-intrinsic Decr2 is necessary for immunotherapy efficacy

| PRJEB75776 | ENA

Tumor cell-intrinsic Decr2 regulates ferroptosis and immunotherapy efficacy

Project description:Tumor cell-intrinsic Decr2 regulates ferroptosis and immunotherapy efficacy

| PRJNA1200063 | ENA

Epigenetic Silencing by SETDB1 Suppresses Tumor-cell Intrinsic Immunogenicity

Project description:Epigenetic Silencing by SETDB1 Suppresses Tumor-cell Intrinsic Immunogenicity

| PRJNA656248 | ENA

Intrinsic RB activation induces tumoral and stromal anti-tumor responses that limit triple-negative breast cancer [scRNA-Seq]

Project description:The RB tumor suppressor is a key regulator of cell cycle progression that is often inactivated in triple-negative breast cancer (TNBC). Recent studies indicate that drugs activating RB have multiple tumor-suppressing effects on the tumor and the tumor microenvironment (TME). Here, we utilize a constitutively active RB protein incapable of being phosphorylated and inactivated by CDKs (RBΔCDK) to assess the intrinsic sufficiency of RB activation on tumor suppression. Expression of RBΔCDK in TNBC cell lines uniformly inhibited proliferation. Transcriptomic analysis revealed suppression of cell cycle genes and the induction of genes associated with interferon response. Similarly, tumor growth and metastasis were suppressed in RBΔCDK expressing human xenograft and mouse syngeneic tumor models. RB activation was sufficient to dramatically alter the TME, wherein tumor growth suppression was mediated by CD8+ T cells. Together, these data indicate that active RB suppresses TNBC progression in cancer cell-autonomous and non-autonomous mechanisms.

2025-11-17 | GSE310026 | GEO

Intrinsic RB activation induces tumoral and stromal anti-tumor responses that limit triple-negative breast cancer [RNA-Seq]

2025-11-17 | GSE310025 | GEO

Tumor cell-intrinsic ATP6V0A1 drives immunosuppressive reprogramming in colorectal cancer

Project description:Tumor cell-intrinsic ATP6V0A1 drives immunosuppressive reprogramming in colorectal cancer

| PRJNA997948 | ENA